Gal-3 is a crucial mediator in the pathophysiology of lung-related inflammatory and fibrotic disorders, including idiopathic pulmonary fibrosis (IPF) and COVID-19 [20]. This evidence concerns the gene LGALS3 and idiopathic pulmonary fibrosis.